Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Microsoft Corporation (MSFT): Q1 EPS Falls Over 20%

Microsoft Corporation (NASDAQ:MSFT) reported its first quarter financials after the closing bell today. On the earnings front, the tech giant reported net income of $4.47 billion, or 53 cents a share. The results are a 22.1% decline from the first quarter of fiscal 2012, where Microsoft reached earnings of 68 cents a share. Unlike last year, when EPS met consensus, analysts were actually expecting the company to come in with a bottom line of 56 cents a share.

Microsoft Corporation (NASDAQ:MSFT)

The 5.4% earnings miss end’s Microsoft’s string of three straight quarterly beats, which propelled the company to a full year FY 2012 EPS of $2.78. Last year’s totals came in 3.1% above consensus estimates, and were 3.3% above FY 2011 earnings. By the end of this year, early consensus is expecting Microsoft to come in with earnings of $3.01, which would be an 8.3% increase from last year.

Despite the miss, Microsoft has some positive growth drivers going forward, most notably its release of the Windows 8 OS next Friday. After trading relatively flat on the day, the stock is down over 2% in after hours trading, and currently sports a P/E ratio that is 7.2% above its five-year historical average of 13.8X. Book and sales valuation metrics, though, show an undervaluation of 15-30%. Factoring in its EPS growth prospects, Microsoft trades at a modest PEG of 1.67.

Continue reading here to check out the hedge fund activity surrounding this stock.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!